Assessing Impinj (PI) Valuation After A Sharp Pullback And Long Term Gains

Advertisement

What recent performance tells you about Impinj (PI)

Impinj (PI) has drawn attention after a month return of about 23% decline and a past 3 months return of about 21% decline, despite a 1 year total return above 12%.

See our latest analysis for Impinj.

With the share price at about $138.10 after a 7 day share price return of around a 15% decline and a 30 day share price return of about a 23% decline, the recent pullback contrasts with a 1 year total shareholder return of roughly 13%. This suggests shorter term momentum has cooled while longer term holders are still in positive territory.

If Impinj has you thinking about where else growth stories might emerge in semiconductors and related areas, it could be a good moment to scan high growth tech and AI stocks for other tech and AI names on your radar.

So with Impinj trading around $138.10, showing an intrinsic discount of about 19% and a wide gap to the average analyst target near $240, is this recent slump a potential opportunity or is the market already pricing in future growth?

Most Popular Narrative: 42.7% Undervalued

With Impinj last closing at about $138.10 against a narrative fair value around $241.11, the current price sits well below that modeled estimate.

Expanding deployment of RFID solutions for food traceability and freshness, especially at the item level driven by pilots with major retailers, presents a multi-year growth opportunity. This trend is underpinned by regulatory and consumer demand for improved traceability and waste reduction, which is already leading to additional pilot programs and is expected to ramp into meaningful unit volumes in 2026 and beyond, supporting outsized future revenue growth.

Read the complete narrative.

Curious what kind of revenue path and margin profile need to line up for that gap between price and fair value to make sense? The narrative leans on strong growth assumptions, rising profitability and a rich future earnings multiple that goes well beyond typical sector levels. If you want to see exactly how those ingredients combine to reach that fair value, the full story is worth a look.

Result: Fair Value of $241.11 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, this story still hinges on a few pressure points, especially reliance on a small number of large customers and the risk that new RFID pilots fail to scale as expected.

Find out about the key risks to this Impinj narrative.

Another way to look at valuation

Even though the narrative suggests Impinj is undervalued versus a fair value of about $241.11, the current P/S ratio of 11.6x tells a different story. It is higher than the US Semiconductor industry at 5.6x, the peer average at 6x, and the fair ratio of 7.8x. This could mean there is less room for error if growth expectations slip. Which signal do you weigh more heavily?

See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:PI P/S Ratio as at Feb 2026
NasdaqGS:PI P/S Ratio as at Feb 2026

Build Your Own Impinj Narrative

If the assumptions behind this view do not sit right with you, you can stress test the same data, adjust the inputs, and Do it your way in under 3 minutes.

A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Impinj.

Ready for more investment ideas?

If you stop with just one stock, you could miss other angles entirely. Use the Simply Wall St Screener to surface fresh, data driven ideas in minutes.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:PI

Impinj

Operates a cloud connectivity platform in the Americas, the Asia Pacific, Europe, the Middle East, and Africa.

High growth potential with adequate balance sheet.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
50 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7719.9% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9217.2% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1907.4% undervalued
24 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

CL
Clive_Thompson
6831 logo
Clive_Thompson on Green Tea Group ·

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend

Fair Value:HK$8.728.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AZ
PRG logo
aziz_22khi on PRG Holdings Berhad ·

WHERE DID THE SIX MILLION SHARES GO? THE PRG OWNERSHIP TRAIL INVESTORS CANNOT IGNORE

Fair Value:RM 0.4477.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
86 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
194 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0